Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Selling, General & Administrative (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) reported Selling, General & Administrative of $29.12 million for Q2 2026, up 44.4% from $20.18 million a year earlier and up 39.8% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Ligand Pharmaceuticals' Selling, General & Administrative came in at $103.43 million, up 16.1% year-over-year; for FY2025, it came in at $92.45 million, up 17.5% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $78.65 million in FY2024 (+49.0%), $52.79 million in FY2023 (-24.7%), $70.06 million in FY2022 (+49.7%) and $46.79 million in FY2021 (-22.0%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since Q4 2022.
  • Year over year, Selling, General & Administrative gained in seven of the last eight quarters, with growth averaging 35.3%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q4 2022 (growth of 147.1%); the low point was Q4 2021 (a decline of 50.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $20.84 million (Q1 2026), $25.03 million (Q4 2025) and $28.45 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 29.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.12 Mn
Mar 31, 2026 20.84 Mn
Dec 31, 2025 25.03 Mn
Sep 30, 2025 28.45 Mn
Jun 30, 2025 20.18 Mn
Mar 31, 2025 18.80 Mn
Dec 31, 2024 25.61 Mn
Sep 30, 2024 24.48 Mn
Jun 30, 2024 17.62 Mn
Mar 31, 2024 10.95 Mn
Dec 31, 2023 15.99 Mn
Sep 30, 2023 14.66 Mn
Jun 30, 2023 11.29 Mn
Mar 31, 2023 10.86 Mn
Dec 31, 2022 31.13 Mn
Sep 30, 2022 14.92 Mn
Jun 30, 2022 12.09 Mn
Mar 31, 2022 11.93 Mn
Dec 31, 2021 12.60 Mn
Sep 30, 2021 10.97 Mn
API Access

Ligand Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LGND&period=max&api_key=YOUR_API_KEY